Skip to content

A study on the prevalence of cow's milk protein allergy in children aged 0-1 years with moderate-to-severe atopic dermatitis

A study on the prevalence of cow's milk protein allergy in children aged 0-1 years with moderate-to-severe atopic dermatitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084031
Enrollment
Unknown
Registered
2024-05-09
Start date
2021-02-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

milk protein allergy

Interventions

Observation Group:Feed amino acid formula powder

Sponsors

Beijing Children's Hospital , Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: (1) Infants aged 0-1 years; (2) Children with moderate-to-severe atopic dermatitis: SCORAD score =25; (3) Pure artificial feeding or mixed feeding; (4) Children with suspected cow's milk protein allergy, meeting one of the following conditions: ? milk protein allergy manifestations in the medical history (rapid onset, late onset); ? previous sIgE positive or SPT positive; ?Atopic dermatitis not controlled by conventional anti-inflammatory effective treatment, especially if accompanied by intestinal motility disorders (abdominal pain, vomiting, change in bowel habits) or growth difficulties; ? No medical history and negative sIgE or/and SPT, but atopic dermatitis is currently thought to be associated with milk protein allergy. (5) No change in living environment for 6 months after enrollment; (6) Voluntary written informed consent signed by the subject's parents or legal guardians.

Exclusion criteria

Exclusion criteria: (1) A diagnosed past history of chronic or major illness; (2) Participation in another clinical trial within the last 3 months; (3) Inability to comply with the study protocol (or the investigator is unsure of the parent's willingness or ability to comply with the protocol requirements). (4) Other conditions that the investigator determines are not appropriate for participation in this study.

Design outcomes

Primary

MeasureTime frame
Confirmation of atopic dermatitis combined with milk protein allergy;

Secondary

MeasureTime frame
SCORAD score;

Countries

China

Contacts

Public ContactMa Lin

Beijing Children's Hospital , Capital Medical University

bch_maleen@aliyun.com+86 136 0130 5676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026